KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,926,000 | -3.0% | 493,584 | +23.7% | 0.01% | 0.0% |
| Q1 2015 | $5,078,000 | +27.8% | 398,911 | +42.1% | 0.01% | +20.0% |
| Q4 2014 | $3,973,000 | +9.9% | 280,804 | +6.8% | 0.01% | +11.1% |
| Q3 2014 | $3,616,000 | -2.2% | 262,966 | +9.4% | 0.01% | 0.0% |
| Q2 2014 | $3,697,000 | -26.9% | 240,361 | -19.0% | 0.01% | -35.7% |
| Q1 2014 | $5,058,000 | +79.9% | 296,817 | +36.8% | 0.01% | +55.6% |
| Q4 2013 | $2,811,000 | -2.3% | 217,031 | -23.8% | 0.01% | -10.0% |
| Q3 2013 | $2,878,000 | +59.9% | 284,901 | +18.2% | 0.01% | +25.0% |
| Q2 2013 | $1,800,000 | – | 241,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |